SCHEMBL30863420

SCHEMBL30863420

COc1ccc(NC(=O)c2ccc(N3CC4(CCN(C)CC4)C3)c(C)c2)c2ccncc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR1D P28221 2/20 0.42
▸ HTR1B P28222 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ WDR5 P61964 4/20 0.40
▸ ABCB1 P08183 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PDE4D Q08499 2/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ WNT1 P04628 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ CNR1 P21554 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27195704 1.00 HTR1D (0.42) HTR1DHTR1BHTR2AMEN1KMT2A
SCHEMBL30863422 0.77 WDR5 (0.49) MEN1KMT2AWDR5ABCB1MAPT
Hydrochloric Acid SCHEMBL30863442 0.77 NPC1 (0.54) NPC1POLBRAB9A
SCHEMBL30863427 0.74 HDAC3 (0.52) PDE4DPDE4APDE4BPDE4C
SCHEMBL27195872 0.73 KDM4E (0.45) KMT2AWDR5NPC1RAB9AMAPT
SCHEMBL27195844 0.70 HSD17B10 (0.49) POLB
SCHEMBL27195818 0.69 AR (0.40) WDR5POLB
SCHEMBL30863383 0.69 PDE4D (0.52) PDE4DPDE4APDE4BPDE4C
Lithium Ion SCHEMBL30806989 0.68 ALDH1A1 (0.37) HTR1DHTR1BHTR2AWDR5NPC1
SCHEMBL30863502 0.68 HDAC3 (0.59) WDR5NPC1RAB9ADYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP claimed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO claimed
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP disclosed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO disclosed
Send feedback